Liver-specific inactivation of Notch2, but not Notch1, compromises intrahepatic bile duct development in mice

Hepatology

Volumn 48, Issue 2, 2008, Pages 607-616

  Geisler, Fabian ^a   Nagl, Florian ^a   Mazur, Pawel K ^a   Lee, Marcel ^a   Zimber Strobl, Ursula ^b   Strobl, Lothar J ^b   Radtke, Freddy ^c   Schmid, Roland M ^a   Siveke, Jens T ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

NOTCH1 RECEPTOR; NOTCH2 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE DUCT; CELL DEGENERATION; CELL DIFFERENTIATION; CELL DISRUPTION; CELL MATURATION; CONTROLLED STUDY; GENE DELETION; GENE DISRUPTION; GENE INACTIVATION; GENE TARGETING; HEPATITIS; HOMEOSTASIS; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; LIVER CELL; LIVER DEVELOPMENT; LIVER FIBROSIS; MOLECULAR DYNAMICS; MORPHOGENESIS; MOUSE; NEWBORN; NONHUMAN; PERINATAL DEVELOPMENT; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN ISOLATION;

ANIMALS; ANIMALS, NEWBORN; BILE DUCTS, INTRAHEPATIC; FIBROSIS; GENE DOSAGE; HEPATOCYTES; LIVER; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; RECEPTOR, NOTCH1; RECEPTOR, NOTCH2; SEVERITY OF ILLNESS INDEX;

EID: 49649111405     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22381     Document Type: Article

References (43)

1. Crawford JM. Development of the intrahepatic biliary tree. Semin Liver Dis 2002;22:213-226.
2. Shiojiri N. Development and differentiation of bile ducts in the mammalian liver. Microsc Res Tech 1997;39:328-335.
3. Lazaridis KN, Scrazzabosco M, Larusso NF. The cholangiopathies: disorders of biliary epithelia. Gastroenterology 2004;127:1565-1577.
4. Li L, Krantz ID, Deng Y, Genin A, Banta AB, Collins CC, et al. Alagille syndrome is caused by mutations in human Jaggedl, which encodes a ligand for Notch1. Nat Genet 1997;16:243-251.
5. Oda T, Elkahloun AG, Pike BL, Okajima K, Krantz ID, Genin A, et al. Mutations in the human Jaggedl gene are responsible for Alagille syndrome. Nat Genet 1997;16:235-242.
6. Emerick KM, Rand EB, Goldmuntz E, Krantz ID, Spinner NB, Piccoli DA. Features of Alagille syndrome in 92 patients: Frequency and relation to prognosis. HEPATOLOGY 1999;29:822-829.
7. j7 Hashida Y, Yunis EJ. Syndromatic paucity of interlobular bile ducts: hepatic histopathology of the early and endstage liver. Pediatr Pathol 1988; 8:1-15.
8. Deutsch GH, Sokol RJ, Stathos TH, Knisely AS. Proliferation to paucity: evolution of bile duct abnormalities in a case of Alagille syndrome. Pediatr Dev Pathol 2001;4:559-563.
9. Novotny NM, Zetterman RK, Antonson DL, VanderhoofJA. Variation in liver histology in Alagille's syndrome. Am J Gastroenterol 1981;75:449-450.
10. Harper JA, Yuan JS, Tan JB, Visan I, Guidos CJ. Notch signaling in development and disease. Clin Genet 2003;64:461-472.
11. Nijjar SS, Crosby HA, Wallace L, Hubscher SG, Strain AJ. Notch receptor expression in adult human liver: A possible role in bile duct formation and hepatic neovascularization. HEPATOLOGY 2001;34:1184-1192.
12. Croquelois A, Blindenbacher A, Terracciano L, Wang X, Langer I, Radtke F, et al. Inducible inactivation of Notchl causes nodular regenerative hyperplasia in mice. HEPATOLOGY 2005;41:497-496.
13. Kodama Y, Hijikata M, Kageyama R, Shimotohno K, Chiba T. The role of notch signaling in the development of intrahepatic bile ducts. Gastroenterology 2004;127:1775-1786.
14. McCrigbt B, Lozier J, Gridley T. A mouse model of Alagille syndrome: Notch2 as a genetic modifier of Jag1 haploinsufficiency. Development 2002;129:1075-1082.
15. Loomes KM, Russo P, Ryan M, Nelson A, Underkoffler I., Glover C, et al. Bile duct proliferation in liver-specific Jag1 conditional knockout mice: Effects of gene dosage. HEPATOLOGY 2007;45:323-330.
16. Shiojiri N, Nagai Y. Preferential differentiation of the bile ducts along the portal vein in the development of mouse liver. Anat Embryol (Berl) 1992; 185:17-24.
17. bRadtke F, Wilson A, Stark G, Bauer M, van Meerwijk J, MacDonald HR, et al. Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity 1999;10:547-558.
18. Besseyrias V, Fiorini E, Strobl LJ, Zimber-Strobl U, Dumortier A, Koch U, et al. Hierarchy of Notch-Delta interactions promoting T cell lineage commitment and maturation. J Exp Med 2007;204:331-343.
19. Postic C, Shiota M, Niswender KD, Jetton TL, Chen Y, Moates JM, et al. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. J Biol Chem 1999;274:305-315.
20. Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 1999;21:70-71.
21. Lewis AK, Frantz GD, Carpenter DA, de Sauvage FJ, Gao WQ Distinct expression patterns of notch family receptors and ligands during development of the mammalian inner ear. Mech Dev 1998;78:159-163.
22. Hamadawa Y, Okabe M, Ikawa M, Coleman JR, Tsujimoto Y. Mutation in ankyrin repeats of the mouse Notch2 gene induces early embryonic lethality. Development 1999;126:3415-3424.
23. Geisler F, Algul H, Paxian S, Schmid RM. Genetic inactivation of RelA/ p65 sensitizes adult mouse hepatocytes toTNF-induced apoptosis in vivo and in vitro. Gastroenterology 2007;132:2489-2503.
24. Greene AK, Puder M. Partial hepatectomy in the mouse: Technique and perioperative management. J Invest Surg 2003;16:99-102.
25. Siveke JT, Einwachter H, Sipos B, Lubeseder-Martellato C, Kloppel G, Schmid RM. Concomitant pancreatic activation of Kras(G12D) and Tgfa results in cystic papillary neoplasms reminiscent of human IPMN. Cancer Cell 2007;12:266-279.
26. Swiatek PJ, Lindsell CE, del Arno FF, Weinmaster G, Gridley T. Notch1 is essential for postimplantation development in mice. Genes Dev 1994;8: 707-719.
27. Xu X, Kobayashi S, Qiao W, Li C, Xiao C, Radaeva S, et al. Induction of intrahepatic cholangiocellular carcinoma by liver-specific disruption of Smad4 and Pten in mice. J Clin Invest 2006; 116:1843-1852.
28. Dutton JR, Chillingworth NL, Eberhard D, Brannon CR, Hornsey MA, Tosh D, et al. Beta cells occur naturally in extrahepatic bile ducts of mice. J Cell Sci 2007; 120:239-245.
29. Shiojiri N. Transient expression of bile-duct-specific cytokeratin in fetal mouse hepatocytes. Cell Tissue Res 1994;278:117-123.
30. Postic C, Magnuson MA. DNA excision in liver by an albumin-Cre transgene occurs progressively with age. Genesis 2000;26:149-150.
31. Hubscher SG, Strain AJ. Another Notch to be added to the list of hepatocellular growth regulatory factors? HEPATOLOGY 2005;41:439-442.
32. Roskams TA, Theise ND, Balabaud C, Bhagat G, Bhathal PS, Bioulac-Sage P, et al. Nomenclature of the finer branches of the biliary tree: Canals, ductules, and ductular reactions in human livers. HEPATOLOGY 2004;39: 1739-1745.
33. Bird TG, Lorenzini S, Forbes SJ. Activation of stem cells in hepatic diseases. Cell Tissue Res 2008;331:283-300.
34. Wang X, Foster M, Al-Dhalimy M, Lagasse E, Finegold M, Grompe M. The origin and liver repopulating capacity of murine oval cells. Proc Natl Acad Sci U S A 2003;100(Suppl 1): 11881-11888.
35. Kuhn R, Schwenk F, Aguet M, Rajewsky K. Inducible gene targeting in mice. Science 1995;269:1427-1429.
36. Yuan ZR, Kobayashi N, Kohsaka T. Human Jagged I mutants cause liver defect in Alagille syndrome by overexpression of hepatocyte growth factor. J Mol Biol 2006;356:559-568.
37. Libbrecht L, Spinner NB, Moore EC, Cassiman D, Van Damme-Lombaerts R, Roskams T. Peripheral bile duct paucity and cholestasis in the liver of a patient with Alagille syndrome: Further evidence supporting a lack of postnatal bile duct branching and elongation. Am J Surg Pathol 2005; 29:820-826.
38. Fabris L, Cadamuro M, Guido M, Spirli C, Fiorotto R, Colledan M, et al. Analysis of liver repair mechanisms in Alagille syndrome and biliary atresia reveals a role for notch signaling. Am J Pathol 2007;171:641-653.
39. McDaniell R, Warthen DM, Sanchez-Lara PA, Pai A, Krantz ID, Piccoli DA, et al. NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway. Am J Hum Genet 2006;79:169-173.
40. Tanimizu N, Miyajima A. Notch signaling controls hepatoblast differentiation by altering the expression of liver-enriched transcription factors. J Cell Sci 2004; 117:3165-3174.
41. Coffinier C, Gresh L, Fiette L, Tronche F, Schutz G, Babinet C, et al. Bile system morphogenesis defects and liver dysfunction upon targeted deletion of HNF1beta. Development 2002;129:1829-1838.
42. Yamasaki H, Sada A, Iwata T, Niwa T, Tomizawa M, Xanthopoulos KG, et al. Suppression of C/EBPalpha expression in periportal hepatoblasts may stimulate biliary cell differentiation through increased Hnf6 and Hnf1b expression. Development 2006;133:4233-4243.
43. Clotman F, Lannoy VJ, Reber M, Cereghini S, Cassiman D, Jacquemin P, et al. The onecut transcription factor HNF6 is required for normal development of the biliary tract. Development 2002;129:1819-1828.